Document is current
Any future updates will be listed below
-
Authors
Ito, Yoshinori https://orcid.org/0000-0002-0135-5589
Hamaguchi, Tetsuya
Takashima, Atsuo
Mizusawa, Junki
Shimada, Yasuhiro
Shiozawa, Manabu
Mizoguchi, Nobutaka
Kodaira, Takeshi
Komori, Koji
Ohue, Masayuki
Konishi, Koji
Teraishi, Fuminori
Kinouchi, Makoto
Murata, Kohei
Fujita, Fumihiko
Watanabe, Masahiko
Iinuma, Gen
Ishida, Fumio
Saida, Yoshihisa
Matsuda, Takahisa
Katayama, Hiroshi
Fukuda, Haruhiko
Kanemitsu, Yukihide
,
-
Funding
Funding for this research was provided by:
National Cancer Center Research and Development Funds (26-A-4, 29-A-3, 2020-J-3, 2023-J-03)
Ministry of Health, Labour and Welfare (H23Gann-012)
- License Information
-
More Information
Article History
Received: 1 October 2022
Accepted: 18 May 2023
First Online: 7 June 2023
Declarations
:
: Tetsuya Hamaguchi has received honoraria and research funding from Taiho Pharmaceutical. All other authors have no disclosures to declare.
: The study protocol was reviewed and approved by the Protocol Review Committee of JCOG and the institutional review board at each institution.
: All patients provided written informed consent.
